ALEXANDRIA, Va. – Kevin Fitzpatrick will step down from his role as Chief Executive Officer of CancerLinQ LLC, a wholly owned non-profit subsidiarity of the American Society of Clinical Oncology (ASCO), on April 13 to pursue a new opportunity outside of ASCO. Richard L. Schilsky, MD, Chief Medical Officer (CMO) of ASCO, will serve as interim CEO. CancerLinQ LLC will initiate a global search for a permanent CEO to oversee the continued expansion and implementation of CancerLinQ®, ASCO’s big data platform designed to improve the quality of care for people with cancer.
ALEXANDRIA, Va. — Linda D. Bosserman, MD, FACP, FASCO, has been named Editor-in-Chief of the Journal of Oncology Practice (JOP), a publication of the American Society of Clinical Oncology (ASCO). Dr. Bosserman is a recognized leader in cancer care delivery with a deep understanding of the issues impacting all types of oncology practices.
The American Society of Clinical Oncology (ASCO) applauds Congress for its bipartisan support of the omnibus spending bill that significantly boosts our nation's investment in biomedical research. By providing a $3 billion funding increase for the National Institutes of Health (NIH) for fiscal year (FY) 2018—the biggest NIH funding increase in 15 years—Congress has taken bold action to regain much-needed momentum in cancer research following a decade of stagnant funding for the NIH.
The American Society of Clinical Oncology (ASCO) and ASCO’s Conquer Cancer Foundation proudly announce the winners of ASCO's Special Awards, the Society's highest honors, and Conquer Cancer’s Women Who Conquer Cancer Mentorship Awards. The recipients of these awards include researchers, patient advocates, and global oncology leaders who have worked to transform cancer care around the world.
Alexandria, Va. - Use of tests that assess genomic variants in circulating tumor DNA (ctDNA) is on the rise. A new joint review from the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) provides an assessment of evidence on ctDNA tests in oncology. It also lays out a framework for future research and clinical practice guidelines to help better inform clinical practice.
ASCO Statement on JAMA Internal Medicine’s Cigarette, Cigar, and Pipe Use Mortality Risk Study
Statement from Bruce E. Johnson, MD, FASCO, President of the American Society of Clinical Oncology (ASCO)
ORLANDO, Fla. – Nine key studies featuring research on survivorship care will be presented at the 2018 Cancer Survivorship Symposium, taking place February 16-17 at the Hyatt Regency Grand Cypress in Orlando, Florida. These select abstracts discuss new insights for the care of patients after cancer treatment, including issues of cost, patient engagement, exercise, late effects of cancer, and insomnia
ALEXANDRIA, VA, FORT WASHINGTON, PA. – Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body’s immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission.
ALEXANDRIA, Va. – A follow-up study to a randomized clinical trial reveals that exercising during adjuvant (post-surgery) chemotherapy helps people engage in more physical activity years later. Four years later, people with breast or colon cancer who had participated in an 18-week exercise program while receiving chemotherapy engaged in physical activity 142 minutes per week or 20 minutes per day more, on average, than those who did not participate in the exercise program. Researchers will present their findings at the upcoming 2018 Cancer Survivorship Symposium in Orlando, Florida.
ALEXANDRIA, Va. – A pilot study of cancer survivors ages 11-15 suggests that a web-based, interactive intervention that provides rewards for exercising can motivate kids to stay physically active. Moderate to vigorous physical activity increased by an average of nearly 5 minutes a week in the group that used the intervention and decreased by an average of over 24 minutes in the control group. These findings will be presented at the upcoming 2018 Cancer Survivorship Symposium in Orlando, Florida.
ALEXANDRIA, Va. – Cancer care guidelines recommend that cancer survivors who experience sexual dysfunction after cancer treatment use therapeutic aids to help improve their sexual health. However, a new study of 25 leading cancer centers found that 87% of the centers reported having no sexual aids available on site for men, and 72% reported having no aids for women. These findings will be presented at the upcoming 2018 Cancer Survivorship Symposium in Orlando, Florida.
ALEXANDRIA, Va. – A new study suggests that a large percentage of adolescents and young adults (AYAs) who have been treated for cancer do not seek follow-up care after their primary treatment ends, despite its importance for long-term health. AYA cancer survivors are at increased risk for heart problems, infertility, and secondary cancers from cancer treatment.
ALEXANDRIA, Va. – New findings from a clinical trial of women with breast cancer suggest that guided exercise with a physical therapist after lymph node dissection helps women regain their range of arm motion more quickly. These findings will be presented at the upcoming 2018 Cancer Survivorship Symposium in Orlando, Florida.
The American Society of Clinical Oncology (ASCO) commends Congress for passing a continuing resolution that includes an important correction to the Merit-based Incentive Payment System. We are also pleased to see a budget deal that commits to at least a $2 billion funding increase for the National Institutes of Health (NIH) to reclaim America’s leadership in cancer research and continue building on our tremendous progress towards understanding, preventing, and treating cancer.